FDA head calls for probe into Alzheimer's drug reviewFDA head calls for probe into Alzheimer's drug reviewFDA head calls for probe into Alzheimer's drug review

FDA head calls for probe into Alzheimer's drug review

The acting head of the Food and Drug Administration called for a government investigation into highly unusual contacts between some of her agency's drug reviewers and the maker of a controversial new Alzheimer's drug.

from Section Page News - Modern Healthcare https://ift.tt/36Fl9sh